Search results for Landogrozumab Biosimilar – Anti-MSTN, GDF8 mAb – Research Grade
Showing 1 – 10 of1products
ID: BAB805405388
Landogrozumab Biosimilar – Anti-MSTN, GDF8 mAb – Research Grade, ProteoGenix, PX-TA1403
Description of Landogrozumab Biosimilar - Anti-MSTN, GDF8 mAb - Research Grade General information on Anti-MSTN/GDF8[Homo sapiens] (Landogrozumab) Monoclonal Antibody Landogrozumab has been investigated for the treatment of Advanced Cancer, Muscular Atrophy, and Pancreatic Cancer.
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.